{"transactions":[{"id":1821881,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2023-07-28T18:30:17.000Z","date":"2023-07-27","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on July 27, 2023 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated July 27, 2023 (the \"Option Agreement\"). The options vest and become exercisable in 12 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":35000,"derivative":{"exercise_price":1.3,"expiration_date":"2033-07-27","underlying":"Common Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-23-025951","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315223025951/ownership.xml","form_type":"4"}},{"id":2043100,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2023-01-30T17:00:34.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 26, 2023 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 26, 2023 (the \"Option Agreement\"). The options vest and become exercisable in 12 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":50000,"derivative":{"exercise_price":0.575,"expiration_date":"2033-01-26","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-23-002971","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315223002971/ownership.xml","form_type":"4"}},{"id":2421892,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2022-01-31T17:57:33.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 27, 2022 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 27, 2022 (the \"Option Agreement\"). The options vest and become exercisable in 12 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":75000,"derivative":{"exercise_price":1.53,"expiration_date":"2032-01-27","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-22-002788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315222002788/ownership.xml","form_type":"4"}},{"id":2891562,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2021-01-29T18:21:37.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 27, 2021 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 27, 2021 (the \"Option Agreement\"). The options vest and become exercisable in 12 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":75000,"derivative":{"exercise_price":3.15,"expiration_date":"2031-01-27","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-21-002153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315221002153/ownership.xml","form_type":"4"}},{"id":3303719,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2020-01-24T17:26:39.000Z","date":"2020-01-22","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 22, 2020 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 22, 2020 (the \"Option Agreement\"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":250000,"derivative":{"exercise_price":1.46,"expiration_date":"2030-01-22","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-20-001089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315220001089/ownership.xml","form_type":"4"}},{"id":3472979,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-07-02T13:38:59.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":5230,"price":1.84,"value":9623.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from January 1, 2019 through June 30, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2019."}],"balance_after":5230,"source":{"system":"sec-edgar","filing":"0001179110-19-008313","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019008313/edgar.xml","form_type":"4"}},{"id":3678869,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2019-02-04T17:21:29.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 31, 2019 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 31, 2019 (the \"Option Agreement\"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date, subject to the reporting person's employment on the relevant vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":300000,"derivative":{"exercise_price":1.67,"expiration_date":"2029-01-31","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-19-001346","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315219001346/ownership.xml","form_type":"4"}},{"id":3678472,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-04T16:35:26.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":173140,"price":5.25,"value":908985.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable in three equal installments over three years starting on the first year anniversary of the grant."}],"balance_after":173140,"derivative":{"exercise_price":5.25,"exercise_date":"2020-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":173140},"source":{"system":"sec-edgar","filing":"0001179110-19-001227","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019001227/edgar.xml","form_type":"4"}},{"id":3980931,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-28T17:14:36.000Z","date":"2018-03-14","kind":"exercise","acquired":false,"shares":912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-03-14","expiration_date":"2018-03-14","underlying":"Common Stock","underlying_shares":912},"source":{"system":"sec-edgar","filing":"0001144204-18-017605","document":"tv489777_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669133/000114420418017605/tv489777_form4.xml","form_type":"4"}},{"id":3980930,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-28T17:14:36.000Z","date":"2018-03-14","kind":"exercise","acquired":true,"shares":912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock."}],"balance_after":912,"source":{"system":"sec-edgar","filing":"0001144204-18-017605","document":"tv489777_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669133/000114420418017605/tv489777_form4.xml","form_type":"4"}},{"id":4382519,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-16T16:16:14.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":18250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units granted by the Issuer pursuant to its 2013 Equity Incentive Plan and qualified under Rule 16b-3(d).  Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest and settle in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest and settle in full one year from the date of grant."}],"balance_after":18250,"derivative":{"underlying":"Common Stock, par value $0.01 per share","underlying_shares":18250},"source":{"system":"sec-edgar","filing":"0001144204-17-015091","document":"v461952_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1669133/000114420417015091/v461952_4.xml","form_type":"4"}},{"id":4382518,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":111063,"kind":"person","name":"McKee Blaine H.","position":1,"cik":"0001669133","reported_name":"McKee Blaine H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-03-16T16:16:14.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares vest in full one year from the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":0.38,"expiration_date":"2027-03-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-17-015091","document":"v461952_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669133/000114420417015091/v461952_4.xml","form_type":"4"}}]}